S. Viñas Diz

S. Viñas Diz

Auto-generated profile, based on publicly available information

S. Viñas Diz

Aging and Inflammatory Research Lab

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

21 March 2011 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
MCMarcelo Chouza
Marcelo Chouza
PAPablo Arias
Pablo Arias
SVSusana Viñas
Susana Viñas
JCJavier Cudeiro
Javier Cudeiro

1 January 2004 in Fisioterapia
Verified
Journal Article
Open access
SBS. Martínez Bustelo
S. Martínez Bustelo
AMAsunción Ferri Morales
Asunción Ferri Morales
SNS. Patiño Nuñez
S. Patiño Nuñez
SDS. Viñas Diz
S. Viñas Diz
ARA. Martínez Rodríguez
A. Martínez Rodríguez
[Resumen] Los programas de reeducación fisioterápica de la región perineal deben basarse en una completa entrevista clínica y valoración funcional de la esfera abdomino-pelvi-perineal. A partir de los datos obtenidos, estableceremos los objetivos de tratamiento y la selección de las técnicas manuales e instrumentales para alcanzar los objetivos planteados. Además de la anamnesis, realizaremos una exploración física exhaustiva del suelo pélvico, que comprenderá la exploración visual y palpatoria, la valoración muscular, la valoración de la estática de los órganos pélvicos y la exploración neurológica; completaremos la valoración específica del suelo pélvico con la valoración abdominal, del diafragma y de la región lumbopélvica.[Abstract] All the physical therapist reeducation programs of the pelvic floor must be based on a thorough clinical interview and functional assessment of the abdominal region, the pelvis and the pelvic floor. From all these data, we will establish the goals o/ the treatment and we will select the manual and instrumental technics to reach the aims we have set out. Besides the clinical interview, we must carry out a comprehensive physical examination of the pelvic floor, which covers the visual and palpable examination, the muscle assessment, the assessment of the biomechanical position of the pelvic organs, and the neurological examination; we must complete the specific assessment of the pelvic floor with the examination of the abdominal region, the diaphragm and the low back

1 July 2016 in Fisioterapia
Verified
Journal Article
Closed access
NGN. Gómez-Regueira
N. Gómez-Regueira
SVS. Viñas-Diz
S. Viñas-Diz

1 January 2003 in Fisioterapia
Verified
Journal Article
Closed access
RCR. Fernández Cervantes
R. Fernández Cervantes
SNS. Patiño Núñez
S. Patiño Núñez
ARA. Martínez Rodríguez
A. Martínez Rodríguez
SDS. Viñas Diz
S. Viñas Diz
GAG. Paseiro Ares
G. Paseiro Ares
MSM. Barcia Seoane
M. Barcia Seoane

1 June 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
JFJ.A. Fernández-Rodríguez
J.A. Fernández-Rodríguez
MAM. Almonte-Becerril
M. Almonte-Becerril
OGOlalla Ramil Gómez
Olalla Ramil Gómez
SVS. Viñas-Diz
S. Viñas-Diz
LHL. Hermida-Carballo
L. Hermida-Carballo
MLMaría J López-Armada
María J López-Armada
Background Previously, we have demonstrated that dietary supplementation with resveratrol (RSV) lowers synovial hyperplasia, chemokines and oxidative damage in an acute antigen-induced arthritis (AIA) model developed in rats, and that autophagic cell death and limiting angiogenic response were involved1. Objectives Here, we investigated the autophagic flux induced by RSV and its relation with serum interleukin (IL)−1β levels, since autophagy could regulate IL-1β via inflammasome. Moreover, C-reactive protein (CRP) and prostaglandin E2 (PGE2), which are also closely linked to inflammation and correlated with disease activity, were also evaluated. Methods Animals were randomly divided into 3 groups: healthy, AIA, and RSV-treated AIA group. RSV (12,5 mg/kg/day) was given orally 8 weeks before AIA induction until sacrifice day (48 hour after intra-articular injection). Healthy and AIA animals were administered 100 µl of water. RSV effects on autophagy were evaluated by the expression of the autophagy proteins, microtubule-associated protein 1 light chain 3 (LC3), and Beclin1 (an autophagic-related protein which up-regulation is associated with increased autophagosome formation), and p62 (an autophagic adaptor protein whose accumulation is associated with autophagic degradation dysfunction), by confocal and immunohistochemistry, respectively. Specific enzyme-linked immunosorbent assay kits and cytokine magnetic milliplex were used to measure CRP and PGE2 and IL-1β in serum samples, respectively. Results At the end of the study, RSV significantly reduced the serum levels of IL-1 β, CRP and PGE2 (p≤0.01 for IL-1β and PCR, and p≤0.05 for PGE2). In relation to autophagy proteins, results showed that the expression of LC3 was greater in the AIA synovial membranes than in control synovial samples, in which the presence of vesicles was easily observed. Interestingly, the synovial tissues from the RSV group showed a significatively (p≤0.001) higher signal for LC3, compared with the AIA samples. As compared with healthy controls, AIA synovial membranes showed increased p62 expression, which was markedly inhibited by RSV treatment (p≤0.01). The protein level of Beclin 1 was higher in AIA synovial membranes than in healthy samples; however, RSV did not increase the signal of Beclin 1. Moreover, there was a significant correlation between p62 expression and serum IL-1β levels (p≤0.05 and r=0.617), PGE2 (p≤0.01 and r=0. 604), and PCR (p≤0.001 and r=0.692). Conclusions These data suggest that resveratrol is capable of inducing the non-canonical (Beclin1 independent) autophagy pathway, and in consequence, modulates the cross-talk existence with inflammation in an acute AIA model, which could also ameliorate the severity of rheumatoid arthritis. Reference [1] Riveiro-Naveira R, Valcárcel N, Almonte M, Vaamonde C, Hermida L, López E, Blanco F, López-Armada MJ. Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis model. Rheumatology2016;55(10):1889–900. Disclosure of Interest None declared